Evaluation of the Impact of Emesis and Emesis plus Purgation Therapy

 

Garg Narendra K

Lecturer Kaya Chikithsa, Mai Bhago Aayurvedic Medical College for Women, Muktsar (Punjab) India.

 

ABSTRACT:

On analysis of collected data ,it has been observed that there were 100 % relieved in intensity of majority of symptoms either alone by Vaman therapy or by combined Vaman plus virechan therapy. There was also symptom like dysentery, loss of hair where there was less (33.33%) impact both of Vaman  or Vaman plus virechan therapy.

 

KEY WORDS: Vaman, Virechan, Positive Health.

 

INTRODUCTION:

Vaman and Virechan therapy is the best therapy for body purification, through which a person get relieved from his entire bodily problem. Our great Acharyas laid down the principle of Vaman, virechan therapy for sure cure of many of the chronic diseases successfully, prevention of disease and thus promotion of positive health. By keeping in mind, the author had undertaken this study to evaluate the impact of Vaman and Vaman plus Virechan therapy by comparing the pre and post impact of therapy on intensity of the symptoms.

 

MATERIALS AND METHODS:

This study was conducted in Pt. Madan Mohan Malviya, Govt. Ayurvedic Medical College, Udaipur (R.J.) between December, 2006 and June, 2007. A total of eight patients having 12 symptoms of various intensity were included in the study. Symptoms were classified as per their intensity and allotted points according to the intensity as follows.

 

TABLE - I

S. No.

Intensity of Symptoms

Points

1.

Very mild

01

2.

Mild

02

3.

Moderate

03

4.

Severe

04

 

The points as per the intensity were added for each patient separately before starting of therapy. Then after emesis therapy again points were added and lastly after emesis plus purgation therapy points were added for comparing the pre and post therapy results. And thus the impact of the emesis and emesis plus purgation therapy was evaluated.

 

The points as per the intensity were added for each patient separately before starting of therapy i.e. pre-therapy. Then after Vaman therapy alone again points were added and lastly after Vaman plus Virechan therapy i.e. post-therapy points were added for comparing the pre and post therapy results. And thus the impact of the Vaman and Vaman plus Virechan therapy was evaluated.

 

For Vaman: -         Intake of milk till comes to the throat i.e. about 2.5 liter.

-      Randia spinosa.

-      Acorus calamus.

-      Saindhava Salt and Honey.


 

TABLE – II

INTENSITY OF SYMPTOMS BEFORE AND AFTER THERAPY

 

S.N.

 

 

 

 

 

 

SYMPTOMS

 

 

 

 

 

 

INTENSITY OF SYMPTOMS BEFORE THERAPY

 

 

RELIEVED AFTER VAMAN THERAPY ALONE

 

 

FURTHER RELIEVED AFTER VAMAN PLUS VIRECHAN THERAPY

 

REMAINING INTENSITY OF SYMPTOMS EVEN AFTER  VAMAN PLUS VIRECHAN

THERAPY

3 – (4 + 5)

TOTAL INTENSITY OF SYMPTOMS RELIEVED

 

 

4 + 5

(1)

(2)

(3)

(4)

(5)

(6)

(7)

1.

Chronic Coryza

11

06 (54.54)

03 (27.27)

02 (18.18)

09 (81.81)

2.

Cough

03

03(100.0)

-

-

03 (100.0)

3.

Acidity

03

02 (66.66)

01 (33.33)

Nil

03 (100.00)

4.

Dysentery

03

Nil (00.0)

01 (33.33)

02 (66.66)

01 (33.33)

5.

Flatulent

03

02 (66.66)

01 (33.33)

Nil

03 (100.00)

6.

Constipation

05

04 (80.0)

01 (20.00)

Nil

05 (100.00)

7.

Loss of Appetite

03

03 (100.0)

-

-

03 (100.0)

8.

Hair fall

13

05 (38.46)

05 (38.46)

03 (23.07)

10 (76.92)

9.

Dry Hair

01

01 (100.0)

-

-

01 (100.0)

10.

Dandruff

07

07 (100.0)

-

-

07 (100.0)

11.

Acne

02

02 (100.0)

-

-

02 (100.0)

12.

Loss of hair on frontal Region of vault

03

Nil (00.0)

01 (33.33)

02 (66.66)

01 (33.33)

Figures in parenthesis indicate percentage.

 

 


For Accessory Emesis.

Infusion of Glycyrrhiza glabra and Saline water.

 

For Purgation: - (i) Cassia fistula, Termenalia chebula, Casia angustifolia, Dry rose and Black salt, Munnacca, Picrorhiza kurroa.

 

Or             (ii) Iccha  Bhedi Ras.

 

OBSERVATIONS AND DISCUSSIONS:

There were 12 symptoms, complained by sampled persons before starting of therapy. As per intensity of symptoms, maximum 13 points accumulated were in favour of hair fall, (Table -II) and minimum 01 point in favour of dry hair. There were 100 % relieved in intensity of symptoms after Vaman therapy  on cough, Loss of appetite, Dry hair, Dandruff and Acne Author further noticed that there were 80 % reduction in intensity of symptoms in Constipation and 66.66 % each in Acidity and Flatulent. Table further revealed that there was 54.54 and 38.46 reduction in intensity of symptoms of chronic coryza and Hair Fall respectively. On further analysis of the collected data i.e. after Vaman plus virechan therapy combined, it has been observed that there was further reduction in intensity of symptoms viz Flatulent, Constipation, chronic coryza and hair fall. Table -II further revealed that there was no impact in intensity of symptoms of Loss of hair of frontal region of Vault by Vaman therapy alone but after Vaman plus virechan therapy combined, it has been observed that there was 33.33% reduction in intensity of symptoms.

 

From above observations and discussions, the author reached to the conclusion that vaman and vaman plus virechan therapy had good impact on the intensity of all of the symptoms .Author expresses the view that more and more such studies must be conducted.

 

In 1957, a World Health Organization (W.H.O.) study group also emphasized that in order to get a comprehensive picture; more and more studies should be carried out.

REFERENCES:

1.       Charak   Sahita;  (1994)  3rd  Edition;   Chowkhaambha  Sur  Bharti   Prakashan;  Varanasi (U.P.).

2.       Bansal A.K., and Chandorkar R.K. Impact of ICDS on morbidity due to nutritional deficiency diseases amongst Tribes and Non Tribes Children ;Research J Science and Tech 2009;1(2) 82-84.

3.       Garg Narendra K. and Bansal A. K. (2001).Management information system in context of Health Care deliveries J. Ravishankar Uni., Vol.14; No. B (Science) 35-40.

 

Received on 14.02.2010

Accepted on 20.04.2010

© A&V Publication all right reserved

Research J. Pharmacology and Pharmacodynamics 2(2): March –April 2010:  201-202